We, however, measured RTKs in metastatic tumours, and there is some evidence that these tumours lose the expression of RTKs as described in an immunohistochemistry study showing that EGFR is lost in metastatic CRC cancer (22). Here, EGFR is linked to metastatic neoplasm.